BMY Operating Expenses

Bristol Myers Squibb · Operating Expenses

BMY logo

BMY Operating Expenses

Latest reported$20.67B
BMY TTM Operating Expenses ($6.09B → $20.67B)
High-resolution chart · PNG

BMY operating expenses history

Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.

Bristol Myers Squibb Operating Expenses — Trailing twelve months (TTM) (USD)
Period endingOperating Expenses (USD)
20,666,000,000
20,567,000,000
20,535,000,000
21,962,000,000
23,577,000,000
25,697,000,000
28,445,000,000
28,254,000,000
27,992,000,000
27,198,000,000
26,118,000,000
26,408,000,000
26,673,000,000
26,749,000,000
26,918,000,000
27,177,000,000
27,725,000,000
28,107,000,000
27,997,000,000
29,616,000,000
28,998,000,000
28,630,000,000
28,568,000,000
24,527,000,000
20,289,000,000
16,175,000,000
12,217,000,000
9,977,000,000
9,903,000,000
11,044,000,000
10,896,000,000
11,471,000,000
11,811,000,000
11,111,000,000
11,269,000,000
10,864,000,000
10,441,000,000
10,104,000,000
9,942,000,000
10,522,000,000
10,577,000,000
11,075,000,000
10,921,000,000
10,748,000,000
10,603,000,000
10,175,000,000
10,233,000,000
9,246,000,000
9,139,000,000
8,852,000,000
8,835,000,000
9,124,000,000
9,212,000,000
9,090,000,000
9,082,000,000
8,996,000,000
9,001,000,000
9,027,000,000
8,999,000,000
9,052,000,000
8,802,000,000
8,565,000,000
8,510,000,000
7,378,000,000
7,460,000,000
7,540,000,000
7,679,000,000
9,159,000,000
9,534,000,000
9,723,000,000
9,797,000,000
9,508,000,000
9,349,000,000
9,313,000,000
9,270,000,000
9,199,000,000
9,185,000,000
9,246,000,000
9,337,000,000
9,375,000,000
9,448,000,000
9,457,000,000
9,328,000,000
9,202,000,000
9,037,000,000
8,927,000,000
8,898,000,000
8,852,000,000
8,761,000,000
8,614,000,000
8,379,000,000
8,109,000,000
7,869,000,000
7,653,000,000
7,436,000,000
7,491,000,000
7,354,000,000
7,430,000,000
7,553,000,000
7,428,000,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.